Table 1.
Participant characteristics
| Characteristic | (n = 67) |
|---|---|
| Sex (female/male) | 35 / 32 |
| Age (years) | 67 ± 7 |
| Body mass index (kg/m2) | 31.2 ± 4.1 |
| Waist circumference (cm) | 105.4 ± 11.9 |
| Impaired fasting glucose a | 11 (16%) |
| Fasting glucose (mmol/L) b | 5.2 ± 0.5 |
| Fasting insulin (pmol/L) b | 51.6 [41.4–74.9] |
| HOMA2%β b | 105 ± 31 |
| HOMA2-IR b | 1.3 ± 0.6 |
| Hypertension c | 25 (37%) |
| Systolic blood pressure (mm Hg) b | 125 ± 14 |
| Diastolic blood pressure (mm Hg) b | 74 ± 10 |
| Resting heart rate (bpm) b | 62 ± 1 |
| Fasting triglycerides (mmol/L) b | 1.2 [0.9–1.6] |
| Fasting total cholesterol (mmol/L) b | 5.2 ± 1.0 |
| Fasting HDL-cholesterol (mmol/L) b | 1.3 ± 0.3 |
| Fasting LDL-cholesterol (mmol/L) b | 3.3 ± 0.8 |
Data expressed as mean ± SD or n (%), fasting insulin and triglycerides are expressed as median [interquartile range]. a Impaired fasting glucose defined as 5.6 mmol/L to 6.9 mmol/L according to current guidelines [25]. b Average of 3 fasting measures across each condition. c hypertension defined as ≥130 mmHg systolic or ≥ 80 mmHg diastolic according to current guidelines [22]